Llwytho...
Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor–positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment.
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Adv Pract Oncol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Harborside Press LLC
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857322/ https://ncbi.nlm.nih.gov/pubmed/33598325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2020.11.3.12 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|